Additionally, Nischarin expression was found to be significantly lower in patients with lymph node metastasis compared with that of patients without lymph node metastasis, suggesting that Nischarin expression levels may be a reliable indicator for the prediction of the invasiveness and metastatic potential of breast cancer. The gene discussed is NISCH; the disease is breast carcinoma.